News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|June 1, 2001

ACOG's 2001 annual meeting: a look back, a step forward

Report on the ACOG 2001 meeting

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage | image credit: stock.adobe.com

Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage

ByJoshua Fitch, Senior Editor

July 21st 2026

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

ByConnor Frey, MD,Joshua Fitch, Senior Editor

July 21st 2026

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

ByDamian Alagia, III, MD, MS, MBA, FACS,

July 20th 2026

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients | Image credit: stock.adobe.com

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

ByJoshua Fitch, Senior Editor

July 20th 2026

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

ByJoshua Fitch, Senior Editor

July 17th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data